Marampon F - Search Results

1

HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

Cassandri M, Porrazzo A, Pomella S, Noce B, Zwergel C, Aiello FA, Vulcano F, Milazzo L, Camero S, Pajalunga D, Spada M, Manzi V, Gravina GL, Codenotti S, Piccione M, Tomaciello M, Signore M, Barillari G, Marchese C, Fanzani A, De Angelis B, Quintarelli C, Vakoc CR, Chen EY, Megiorni F, Locatelli F, Valente S, Mai A, Rota R, Marampon F. Cassandri M, et al. Among authors: marampon f. Cell Death Discov. 2024 Aug 6;10(1):351. doi: 10.1038/s41420-024-02115-y. Cell Death Discov. 2024. PMID: 39107280 Free PMC article.

2

Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells.

Antinozzi C, Marampon F, Corinaldesi C, Vicini E, Sgrò P, Vannelli GB, Lenzi A, Crescioli C, Di Luigi L. Antinozzi C, et al. Among authors: marampon f. J Endocrinol Invest. 2017 Oct;40(10):1133-1143. doi: 10.1007/s40618-017-0686-y. Epub 2017 May 15. J Endocrinol Invest. 2017. PMID: 28508346 Free PMC article.

3

HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.

Vulcano F, Ciccarelli C, Mattia G, Marampon F, Giampiero M, Milazzo L, Pascuccio M, Zani BM, Giampaolo A, Hassan HJ. Vulcano F, et al. Among authors: marampon f. Exp Cell Res. 2006 May 15;312(9):1590-7. doi: 10.1016/j.yexcr.2006.01.017. Exp Cell Res. 2006. PMID: 16739251

4

5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.

Gravina GL, Marampon F, Di Staso M, Bonfili P, Vitturini A, Jannini EA, Pestell RG, Tombolini V, Festuccia C. Gravina GL, et al. Among authors: marampon f. Prostate. 2010 Aug;70(11):1166-78. doi: 10.1002/pros.21151. Prostate. 2010. PMID: 20333699

5

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.

Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, Tombolini V. Gravina GL, et al. Among authors: marampon f. Mol Cancer. 2010 Nov 25;9:305. doi: 10.1186/1476-4598-9-305. Mol Cancer. 2010. PMID: 21108789 Free PMC article. Review.

6

MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.

Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, Fardella C, Polidoro L, Ciccarelli C, Festuccia C, Popov VM, Pestell RG, Tombolini V, Zani BM. Marampon F, et al. Mol Cancer Ther. 2011 Jan;10(1):159-68. doi: 10.1158/1535-7163.MCT-10-0631. Mol Cancer Ther. 2011. PMID: 21220498 Free PMC article.

7

Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib.

Gravina GL, Marampon F, Piccolella M, Biordi L, Ficorella C, Motta M, Jannini EA, Tombolini V, Festuccia C. Gravina GL, et al. Among authors: marampon f. Prostate. 2011 Oct 1;71(14):1481-91. doi: 10.1002/pros.21363. Epub 2011 Mar 28. Prostate. 2011. PMID: 21446006

8

The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.

Gravina GL, Marampon F, Petini F, Biordi L, Sherris D, Jannini EA, Tombolini V, Festuccia C. Gravina GL, et al. Among authors: marampon f. Endocr Relat Cancer. 2011 Jul 1;18(4):385-400. doi: 10.1530/ERC-11-0045. Print 2011 Aug. Endocr Relat Cancer. 2011. PMID: 21551258

9

Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.

Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C. Gravina GL, et al. Among authors: marampon f. Int J Oncol. 2012 Mar;40(3):711-20. doi: 10.3892/ijo.2011.1270. Epub 2011 Nov 23. Int J Oncol. 2012. Retraction in: Int J Oncol. 2025 Feb;66(2):11. doi: 10.3892/ijo.2025.5717 PMID: 22134754 Retracted.

10

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.

Gravina GL, Ranieri G, Muzi P, Marampon F, Mancini A, Di Pasquale B, Di Clemente L, Dolo V, D'Alessandro AM, Festuccia C. Gravina GL, et al. Among authors: marampon f. Oncol Rep. 2013 Mar;29(3):1189-95. doi: 10.3892/or.2012.2192. Epub 2012 Dec 18. Oncol Rep. 2013. PMID: 23254386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters